Skip to main navigation Skip to search Skip to main content

Naturally HIV-1 seroconverters with lowest viral load have best prognosis, but in time lose control of viraemia

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Candidate AIDS vaccines are based on the success of monkey studies, showing the ability of vaccine-induced cytotoxic T lymphocytes to control HIV-1 replication. We evaluated the ability to maintain suppression of virus replication in seroconverters with a naturally low level of plasma HIV-1 RNA. No AIDS-defining events were observed at low plasma HIV-1-RNA levels, but a steady loss of CD4 T lymphocytes occurred, and long-term control of viraemia was extremely rare in the natural course of HIV-1 infection
Original languageEnglish
Pages (from-to)791-793
Number of pages3
JournalAIDS (London, England)
Volume16
Issue number5
DOIs
Publication statusPublished - 29 Mar 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Naturally HIV-1 seroconverters with lowest viral load have best prognosis, but in time lose control of viraemia'. Together they form a unique fingerprint.

Cite this